John Hester
Stock Analyst at Bell Potter
(3.96)
# 1,745
Out of 4,411 analysts
199
Total ratings
46.5%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: PGC Paragon Care Limited | Downgraded: Hold | $0.30 → $0.17 | $0.145 | +17.24% | 17 | Jun 2, 2026 | |
| ASX: 4DX 4DMedical Limited | Maintained: Buy | $4.50 → $6.00 | $3.74 | +60.43% | 13 | Jun 2, 2026 | |
| ASX: IMU Imugene Limited | Maintained: Buy | $0.25 | $0.10 | +150.00% | 7 | May 28, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $1.12 → $1.09 | $0.64 | +70.31% | 6 | May 26, 2026 | |
| ASX: DOC Doctor Care Anywhere Group PLC | Upgraded: Buy | $0.20 → $0.24 | $0.12 | +100.00% | 4 | May 21, 2026 | |
| ASX: CYC Cyclopharm Limited | Maintained: Buy | $1.00 | $0.555 | +80.18% | 13 | May 10, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $19.00 | $14.25 | +33.33% | 31 | May 8, 2026 | |
| ASX: MSB Mesoblast Limited | Maintained: Buy | $4.45 | $1.96 | +127.39% | 18 | May 1, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $240.00 → $226.00 | $163.89 | +37.90% | 15 | Apr 14, 2026 | |
| ASX: CU6 Clarity Pharmaceuticals Ltd | Maintained: Buy | $6.40 → $6.50 | $2.24 | +190.18% | 19 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.00 → $13.00 | $12.86 | +1.09% | 4 | Mar 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.00 | $2.82 | +6.38% | 4 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $4.10 → $3.60 | $3.16 | +13.92% | 16 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.00 → $1.80 | $0.99 | +81.82% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.05 → $0.06 | $0.02 | +200.00% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.73 → $0.65 | $0.165 | +293.94% | 9 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.037 | +305.41% | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.004 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.84 → $3.82 | $3.82 | n/a | 3 | Nov 25, 2022 |
Paragon Care Limited
Jun 2, 2026
Downgraded: Hold
Price Target: $0.30 → $0.17
Current: $0.145
Upside: +17.24%
4DMedical Limited
Jun 2, 2026
Maintained: Buy
Price Target: $4.50 → $6.00
Current: $3.74
Upside: +60.43%
Imugene Limited
May 28, 2026
Maintained: Buy
Price Target: $0.25
Current: $0.10
Upside: +150.00%
Aroa Biosurgery Limited
May 26, 2026
Maintained: Buy
Price Target: $1.12 → $1.09
Current: $0.64
Upside: +70.31%
Doctor Care Anywhere Group PLC
May 21, 2026
Upgraded: Buy
Price Target: $0.20 → $0.24
Current: $0.12
Upside: +100.00%
Cyclopharm Limited
May 10, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.555
Upside: +80.18%
Telix Pharmaceuticals Limited
May 8, 2026
Maintained: Buy
Price Target: $19.00
Current: $14.25
Upside: +33.33%
Mesoblast Limited
May 1, 2026
Maintained: Buy
Price Target: $4.45
Current: $1.96
Upside: +127.39%
Pro Medicus Limited
Apr 14, 2026
Maintained: Buy
Price Target: $240.00 → $226.00
Current: $163.89
Upside: +37.90%
Clarity Pharmaceuticals Ltd
Apr 1, 2026
Maintained: Buy
Price Target: $6.40 → $6.50
Current: $2.24
Upside: +190.18%
Mar 8, 2026
Maintained: Buy
Price Target: $10.00 → $13.00
Current: $12.86
Upside: +1.09%
Feb 27, 2026
Maintained: Hold
Price Target: $3.00
Current: $2.82
Upside: +6.38%
Feb 24, 2026
Upgraded: Hold
Price Target: $4.10 → $3.60
Current: $3.16
Upside: +13.92%
Feb 23, 2026
Maintained: Buy
Price Target: $2.00 → $1.80
Current: $0.99
Upside: +81.82%
Dec 17, 2025
Maintained: Buy
Price Target: $0.05 → $0.06
Current: $0.02
Upside: +200.00%
Sep 30, 2025
Maintained: Buy
Price Target: $0.73 → $0.65
Current: $0.165
Upside: +293.94%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.037
Upside: +305.41%
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.004
Upside: n/a
Nov 25, 2022
Maintained: Hold
Price Target: $4.84 → $3.82
Current: $3.82
Upside: n/a